Products
Platform
Research
Market
Learn
IPO
Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.1 | 1.93 |
NAV | ₹30.91 | ₹434.00 |
Fund Started | 04 Dec 2015 | 04 Jun 1999 |
Fund Size | ₹1324.90 Cr | ₹4082.13 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.1
1.93
NAV
₹30.91
₹434.00
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1324.90 Cr
₹4082.13 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 4.99% | 5.01% |
3 Year | 21.94% | 24.57% |
5 Year | 17.77% | 19.33% |
1 Year
4.99%
5.01%
3 Year
21.94%
24.57%
5 Year
17.77%
19.33%
Holding Analysis
Equity | 98.47% | 96.05% |
Cash | 1.53% | 3.88% |
Equity
98.47%
96.05%
Cash
1.53%
3.88%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.59% |
Apollo Hospitals Enterprise Ltd. | 5.13% |
Healthcare Global Enterprises Ltd. | 4.96% |
Lupin Ltd. | 4.90% |
Max Healthcare Institute Ltd. | 4.71% |
Torrent Pharmaceuticals Ltd. | 4.52% |
Alkem Laboratories Ltd. | 4.42% |
Abbott India Ltd. | 4.02% |
Cipla Ltd. | 3.92% |
Ipca Laboratories Ltd. | 3.56% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.18% |
Divi's Laboratories Ltd. | 7.26% |
Max Healthcare Institute Ltd. | 5.62% |
Cipla Ltd. | 4.41% |
Lonza Group Ag | 4.05% |
Lupin Ltd. | 4.04% |
Acutaas Chemicals Ltd. | 3.81% |
Fortis Healthcare Ltd. | 3.76% |
Torrent Pharmaceuticals Ltd. | 3.49% |
Jupiter Life Line Hospitals Ltd. | 3.46% |
Fund Manager
Name | Meeta Shetty | Tanmaya Desai |
Start Date | 11 Nov 2024 | 17 May 2024 |
Name
Meeta Shetty
Tanmaya Desai
Start Date
11 Nov 2024
17 May 2024
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 04 Dec 2015 | 04 Jun 1999 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999